{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:57:48Z","timestamp":1786989468362,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["fsijournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.forsciint.2014.04.017","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:30:15Z","timestamp":1397608215000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"special_numbering":"C","title":["A 3-year review of new psychoactive substances in casework"],"prefix":"10.1016","volume":"243","author":[{"given":"Simon","family":"Elliott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2014.04.017_bib0005","series-title":"Annual Report on the State of the Drugs Problem in Europe","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2012"},{"key":"10.1016\/j.forsciint.2014.04.017_bib0010","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/dta.315","article-title":"Some new psychoactive substances: precursor chemicals and synthesis-driven end-products","volume":"3","author":"Collins","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/dta.310","article-title":"Social, policy, and public health perspectives on new psychoactive substances","volume":"3","author":"Sumnall","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chroma.2012.12.049","article-title":"New challenges and innovation in forensic toxicology: focus on the New Psychoactive Substances","volume":"1287","author":"Favretto","year":"2013","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4155\/bio.10.206","article-title":"Cat and mouse: the analytical toxicology of designer drugs","volume":"3","author":"Elliott","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.forsciint.2014.04.017_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/dta.317","article-title":"Reference materials for new psychoactive substances","volume":"3","author":"Archer","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/dta.1420","article-title":"A.M.T. (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis","volume":"5","author":"Elliott","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0040","article-title":"An investigation of the stability of emerging new psychoactive substances","author":"Soh","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0045","series-title":"The High Prevalence of Cathinone-derivatives in Suicides\u2014A Comparative Study","author":"Durkin","year":"2010"},{"issue":"9","key":"10.1016\/j.forsciint.2014.04.017_bib0050","doi-asserted-by":"crossref","first-page":"e003247","DOI":"10.1136\/bmjopen-2013-003247","article-title":"Suicide-related events in young people following prescription of SSRIs and other antidepressants: a self-controlled case series analysis","volume":"3","author":"Wijlaars","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.forsciint.2014.04.017_bib0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.330.7488.385","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review","volume":"330","author":"Gunnell","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.forsciint.2014.04.017_bib0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/15563650.2011.645952","article-title":"\u2018Legal highs\u2019\u2014novel and emerging psychoactive drugs: a chemical overview for the toxicologist","volume":"50","author":"Gibbons","year":"2012","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.forsciint.2014.04.017_bib0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1081\/CLT-200058950","article-title":"Key concepts in postmortem drug redistribution","volume":"43","author":"Yarema","year":"2005","journal-title":"Clin. Toxicol (Phila.)"},{"key":"10.1016\/j.forsciint.2014.04.017_bib0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.forsciint.2012.01.016","article-title":"Evaluation of postmortem redistribution phenomena for commonly encountered drugs","volume":"219","author":"Han","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0075","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/jat\/bks094","article-title":"Mephedrone (methylmethcathinone) in toxicology casework: a Northern Ireland perspective","volume":"37","author":"Cosbey","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0080","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/anatox\/35.3.188","volume":"35","author":"Maskell","year":"2011","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jat\/bks138","article-title":"The stability of four designer drugs: MDPV, mephedrone, BZP and TFMPP in three biological matrices under various storage conditions","volume":"37","author":"Johnson","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0090","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jchromb.2011.02.010","article-title":"Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography\u2013electrospray tandem mass spectrometry","volume":"879","author":"S\u00f8rensen","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.forsciint.2014.04.017_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2013.06.016","article-title":"Clinical pharmacological aspects of bath salt use: a review of the literature and case reports","volume":"132","author":"Miotto","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","article-title":"The toxicology of bath salts: a review of synthetic cathinones","volume":"8","author":"Prosser","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0105","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/15563650.2011.615318","article-title":"Clinical toxicology of newer recreational drugs","volume":"49","author":"Hill","year":"2011","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s13181-013-0287-x","article-title":"Recurrent seizures and serotonin syndrome following 2C-I ingestion","volume":"9","author":"Bosak","year":"2013","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.annemergmed.2011.11.033","article-title":"Serotonin syndrome associated with MDPV use: a case report","volume":"60","author":"Mugele","year":"2012","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13181-011-0199-6","article-title":"Lethal serotonin syndrome after methylone and butylone ingestion","volume":"8","author":"Warrick","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hup.2298","article-title":"M.D.A.I. (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; \u2018sparkle\u2019; \u2018mindy\u2019) toxicity: a brief overview and update","volume":"28","author":"Corkery","year":"2013","journal-title":"Hum. Psychopharmcol."},{"key":"10.1016\/j.forsciint.2014.04.017_bib0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pnpbp.2012.05.021","article-title":"2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): a preliminary review","volume":"39","author":"Corkery","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073814001571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073814001571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T18:26:52Z","timestamp":1538677612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073814001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":26,"alternative-id":["S0379073814001571"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2014.04.017","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 3-year review of new psychoactive substances in casework","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2014.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}